Diabetes

Metformin - biguanide with antihyperglycemic effect. Reduces glucose levels in blood plasma both onset and after eating. Metformin reduces glucose production in the liver, improves insulin sensitivity in muscle and utilizes glucose, inhibits glucose uptake in the intestine. Clinically proven that Metformin has a positive effect on lipid metabolism: it lowers total cholesterol, low density lipoprotein, and triglycerides. Tablets 500 and 1000 mg №30, №60.

Exclusive distributor of the products – PrJSC “Indar”

Test for diagnostic of Sudomotoric Dysfunction and for early detection of Diabetic Foot Syndrome. The indicator changes its color respectively to extent of dysfunction of c-nerves responsible for performance of foot sweat glands. Can be used by medical professionals for express-diagnostic and for self-monitoring by people with diabetes.

ReDerma anti-flaking stocking with innovative copper fibres technology to prevent diabetic foot.

Reusable pen for insulin cartridges id Pen can administer insulin doses from 1 to 60 insulin units (I.U.) in increments of one insulin unit each.

id Pen is designed to be used with insulin cartridges produced by PrJSC "INDAR" and compatible needles.

The list of compatible needles can be found under Instruction for Use. Do not store with needles.

Avoid direct light, moister and dust. id Pen has 3 years functional life from the date of purchase.

CAUTION! Read the Instruction for Use before using id Pen.

PrJSC “Indar” – exclusive distributor in Ukraine

Needles Insupen are produced in accordance with European quality standard EN ISO 11608-2:2000 "TYPE А" and are adaptable to all insulin syringe pens available on the market.

Exclusive distributor in Ukraine: PrJSC "INDAR" Sterile Insulin Syringes with needle 31G/30G/29G with magnifying lens from PIC technology - a real breakthrough in diabetes therapy.

PrJSC “Indar” – exclusive distributor in Ukraine

Convenient device that is coded automatically. Can be used for individual and professional use.

• Accurate and fast result
• Easy to use
• Hygiene control
• Large memory capacity (500 memory with 5 user ID)
• Blood micro sample
• PC link

Short-acting insulin

Human recombinant insulin. Anti-diabetic product of short effect. Ensures quick decrease of glucose level in the blood, intensifies its absorption by tissues. The effect starts after 30 minutes and can last within 5-7 hours depending on the dosage.

Solution for injection in 3 ml cartridges (100 IU/ml) No 3 and No 5

Human recombinant insulin. Anti-diabetic product of short effect. Ensures quick decrease of glucose level in the blood, intensifies its absorption by tissues. The effect starts after 30 minutes and can last within 5-7 hours depending on the dosage.

Solution for injection in 10 ml vials (100 IU/ml) No 1

Intermediate-acting insulin

Human recombinant insulin. Anti-diabetic product of intermediate effect, that ensures decrease of glucose level in the blood, intensifies its absorption by tissues. Has slow release and continuous therapeutical effect. The effect starts after 1 hour upon injection and can last for 12-20 hours.

Suspension for injection in 3 ml cartridges (100 IU/ml) No 3 and No 5

Human recombinant insulin. Anti-diabetic product of intermediate effect, that ensures decrease of glucose level in the blood, intensifies its absorption by tissues. Has slow release and continuous therapeutical effect. The effect starts after 1 hour upon injection and can last for 12-20 hours.

Suspencion for injection in 10 ml vials (100 IU/ml) No 1

Combination insulin

Human recombinant insulin. Anti-diabetic product of mixed intermediate and short-effect insulin, that ensures decrease of glucose level in the blood, intensifies its absorption by tissues. Has fast release and continuous therapeutical effect. The effect starts after 30-45 minutes upon injection and can last for 12-16 hours (depending on dosage and individual peculiarities of body).

Suspension for injection in 3 ml cartridges (100 IU/ml) No 1, No 5

Human recombinant insulin. Anti-diabetic product of mixed intermediate and short-effect insulin, that ensures decrease of glucose level in the blood, intensifies its absorption by tissues. Has fast release and continuous therapeutical effect. The effect starts after 30-45 minutes upon injection and can last for 12-16 hours (depending on dosage and individual peculiarities of body).

Suspension for injection in 10 ml vials (100 IU/ml) No 1